“…Administration of LT by virtually any mucosal route first activates innate immune responses, including secretion of inflammatory cytokines, dendritic cell (DC) recruitment and activation, and initiation of antigen presentation (1,21,47,50,54). Subsequently, antigen-specific adaptive immune responses develop, including IgG1/IgG2a antibodies, mucosal IgA, and mixed Th1/ Th2/Th17/Treg cellular responses, depending upon the intrinsic nature of the coadministered antigen, the type of attenuating mutation to the LT (if any), and the route of immunization (3,6,13,24,37,41,42,53,55).…”